Target intelligence / Profile preview

Ribosomal protein L36 pseudogene 19 (RPL36P19)

Target: RPL36P19
Molecular classification: Other (Pseudogene)

Overview

RPL36P19 (Ribosomal protein L36 pseudogene 19) is a processed pseudogene in the human genome, corresponding to the ribosomal protein L36 gene family. It does not encode a functional protein and is not believed to have any direct biological activity or therapeutic relevance. Processed pseudogenes like RPL36P19 are typically nonfunctional genetic elements derived from functional ribosomal protein genes and do not contribute to protein synthesis or other biological processes[5][6].

Other names: RPL36P19

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene 19 (RPL36P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene 19 (RPL36P19).

Explore the full profile